Unveiling the Spectrum of Nosocomial Candiduria: A Cross-Sectional Analysis in a Tertiary Care Hospital of Punjab, Pakistan
DOI:
https://doi.org/10.36283/ziun-pjmd14-2/030Keywords:
Candidiasis, Urinary Tract Candida Species, Drug Resistance, Fungal, Nosocomial Infection, Antifungal Resistance, Antifungal Agents, Urinary Tract InfectionsAbstract
Background: Bacteriuria and urinary tract infections (UTIs) top the list of prevalent nosocomial infections worldwide; Candida species have recently emerged as important pathogens in UTIs. Nosocomial candiduria refers to the identification of Candida in urine samples of hospital-admitted patients and has lately become prevalent, common among patients with protracted hospital stay, comorbidities, and invasive devices, including urinary catheters. Candida albicans has been found to cause candiduria most often in the past; however, new data show that NAC species are a rising trend. Candida tropicalis and Candida glabrata, as part of these NAC species are regarded with high risks for antifungal resistance, making their clinical assessment complex. This study aimed to discover the spectrum of Candida species causing nosocomial candiduria in a tertiary care hospital in Punjab, Pakistan, and to highlight the increasing trend of non-albicans Candida species.
Methods: This was a cross-sectional study in which 2,500 urine samples were collected from August 2023 to February 2024 from different wards of the Jinnah hospital and cultured on cysteine lactose electrolyte deficient (CLED) agar using standard microbiological techniques. Non-probability consecutive technique was used. The incubation period was 48-72 hours at 37°C. Candida species were identified based on colony morphology, Gram stain, Germ tube test, and sub-culturing on Chrom Candida Agar. Confirmation was done using an API Candida yeast identification panel (Biomerieux, France) by carbohydrate assimilation. Data was analyzed using SPSS 20.0. Categorical characters were summarized using frequencies of each category and the percentage that each category represented (e.g., distribution of Candida species, gender, and age groups). Crosstabulation and chi-square test were used to determine the relationship between nominal variables, including gender and Candida species. For nominal variables (e.g., gender), independent chi-square tests were used as the analysis since they test for differences in proportions. In this study, the level of significance for the test of hypotheses was set at 0.05.
Results: Out of 2,500 patients [1500 (60%) female, 1000 (40%) male], 17.96% (n=449) had Candida growth. Non-albicans Candida species were found to be more common at 69.2% (n=311), whereas Candida albicans was 30.73% (n=138). The most common species were C. tropicalis (41.2%) and C. glabrata (20%). Candiduria was more common in females and patients above 51 years of age.
Conclusion: The high prevalence of non-albicans Candida species in nosocomial candiduria cases emphasizes the need for species-level identification for effective antifungal therapy. With increasing resistance in non-albicans Candida species, early and accurate diagnosis is a must for optimal management. This study recommends targeted antifungal therapy and regular surveillance to combat the growing problem of candiduria in hospitals.
References
Aggarwal N, Leslie S, Lotfollahzadeh S. Recurrent urinary tract infections. StatPearls. 2024;
Salam MA, Al-Amin MY, Salam MT, et al. Antimicrobial resistance: a growing serious threat to global public health. MDPI; 2023:1946.DOI: 10.3390/healthcare11131946
Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000–2009). BMC Infectious Diseases. 2013;13(1):19 .DOI: 10.1186/1471-2334-13-19
Zarb P, Coignard B, Griskeviciene J, et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Eurosurveillance. 2012;17(46):20316. DOI: 10.2807/ese.17.46.20316-en
Alkilani AA, Shalakany AHE, El-Masry EA, Awad ET, Mohamad EA. Nosocomial Candiduria in Critically Ill Patients Admitted to Intensive Care Units in Menoufia University Hospitals, Egypt. 2016.
Vedachalam SK, Thakur AK, Parveen R, et al. P25 Healthcare-associated candiduria in ICU patients: experience from a surveillance network in India, 2017–22. JAC-Antimicrobial Resistance. 2023;5(Supplement_3):dlad077.029.DOI: 10.1093/jacamr/dlad077.029
Alduraywish AA. Case Report: Diabetic urinary auto-brewery and review of literature [version 1; peer review: 1 approved]. 2021.DOI: 10.12688/f1000research.72688.1
Malik AW, Awad AK, Qaddoori HT. Candida species are associated with urinary tract infections. World Journal of Advanced Research and Reviews. 2022;16(1):111-121.DOI: 10.30574/wjarr.2022.16.1.0307
da Silveira Ferreira IC, de Paula Menezes R, de Jesus TA, et al. Unraveling the Epidemiology of Urinary Tract Infections in Neonates: Perspective from a Brazilian NICU. American Journal of Infection Control. 2024.DOI: 10.1016/j.ajic.2023.11.007
Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. Journal of Clinical Microbiology. 1994;32(8):1923-1929.DOI: 10.1128/jcm.32.8.1923-1929.1994
Pfaller MA, Houston A, Coffmann S. Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. Journal of Clinical Microbiology. 1996;34(1):58-61.DOI: 10.1128/jcm.34.1.58-61.1996
Bavanandan S, Keita N. Urinary Tract Infection Prevention and Treatment. Elsevier; 2024:151468.DOI: 10.1016/B978-0-323-85151-4.00036-8
Farhan MS, Abdullah BA, Mamdwooh AE, Numan RS. Review of Virulence Factors in Candida. Journal for Research in Applied Sciences and Biotechnology. 2024;3(2):75-82.DOI: 10.5281/zenodo.10012345
Lass-Flörl C, Kanj SS, Govender NP, Thompson III GR, Ostrosky-Zeichner L, Govrins MA. Invasive candidiasis. Nature Reviews Disease Primers. 2024;10(1):20.DOI: 10.1038/s41572-024-00456-7
Iman K, Shorouk K, Muhmoud M. Candida infection associated with urinary catheter in critically ill patients. Identification, antifungal susceptibility, and risk factors. J of Med & Med sciences. 2010;5(1):79-86.
Yashavanth R, Shiju M, Bhaskar U, Ronald R, Anita K. Candiduria: prevalence and trends in antifungal susceptibility in a tertiary care hospital of Mangalore. Journal of Clinical and Diagnostic Research: JCDR. 2013;7(11):2459.DOI: 10.7860/JCDR/2013/6298.3578
Febré N, Silva V, Medeiros EAS, Wey SB, Colombo AL, Fischman O. Microbiological Characteristics of Yeasts Isolated from Urinary Tracts of Intensive Care Unit Patients Undergoing Urinary Catheterization. Journal of Clinical Microbiology. 1999;37(5):1584-1586.DOI: 10.1128/JCM.37.5.1584-1586.1999
Mesini A, Bandettini R, Caviglia I, et al. Candida infections in paediatrics: Results from a prospective single‐centre study in a tertiary care children's hospital. Mycoses. 2017;60(2):118-123.DOI: 10.1111/myc.12563
Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrobial Agents and Chemotherapy. 1995;39(1):1-8.DOI: 10.1128/AAC.39.1.1
Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD. Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Frontiers in Microbiology. 2017;7:2173.DOI: 10.3389/fmicb.2016.02173

Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Medicine and Dentistry

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/